Can a new drug shield nerves from Chemotherapy's side effects?
Prevention
Not yet recruiting
This phase 2 trial is testing an experimental drug called SIR2501 in adults with solid tumors who are about to receive paclitaxel-based chemotherapy. The goal is to see if SIR2501 is safe, tolerable, and might reduce the development of chemotherapy-induced peripheral neuropathy—a…
Phase: PHASE2 • Sponsor: Sironax USA, Inc. • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC